UB Paderborn / Katalog / Suche / in CDI

Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study

The Lancet (British edition), 2014-05, Vol.383 (9932), p.1889-1898

2014

Volltextzugriff (PDF)

Etripamil Nasal Spray for Recurrent Paroxysmal Supraventricular Tachycardia Conversion

Journal of the American College of Cardiology, 2024-05, Vol.83 (20), p.2032-2034

2024

Volltextzugriff (PDF)

Rationale and design of the NODE-303 study: evaluating the safety of symptom-prompted, self-administered etripamil for paroxysmal supraventricular tachycardia episodes in real-world settings

The American heart journal, 2024-04, Vol.270, p.55-61

2024

Volltextzugriff (PDF)

Plain language summary of the safety and effectiveness of etripamil for atrioventricular-nodal-dependent supraventricular tachycardia: the RAPID study

Future cardiology, 2024-02, Vol.20 (2), p.35-44

2024

Volltextzugriff (PDF)

Design and Rationale of a Phase 2 Study of NeurOtoxin (Botulinum Toxin Type A) for the PreVention of Post-Operative Atrial Fibrillation – The NOVA Study

The American heart journal, 2022-03, Vol.245, p.51-59

2022

Volltextzugriff (PDF)

Results of a curtailed randomized controlled trial, evaluating the efficacy and safety of azimilide in patients with implantable cardioverter defibrillators: The SHIELD-2 trial

The American heart journal, 2017-03, Vol.185, p.43-51

2017

Volltextzugriff (PDF)

Multicenter, Phase 2, Randomized Controlled Study of the Efficacy and Safety of Etripamil Nasal Spray for the Acute Reduction of Rapid Ventricular Rate in Patients With Symptomatic Atrial Fibrillation (ReVeRA-201)

Circulation. Arrhythmia and electrophysiology, 2023-12, Vol.16 (12), p.639

2023

Volltextzugriff (PDF)

Refinement of the Magnetic Resonance Diffusion-Perfusion Mismatch Concept for Thrombolytic Patient Selection Insights From the Desmoteplase in Acute Stroke Trials

Stroke (1970), 2012-09, Vol.43 (9), p.2313-2318

2012

Volltextzugriff (PDF)

Efficacy of nebivolol‐valsartan single‐pill combination in obese and nonobese patients with hypertension

The journal of clinical hypertension (Greenwich, Conn.), 2017-06, Vol.19 (6), p.632-639

2017

Volltextzugriff (PDF)

Efficacy and tolerability of a nebivolol-valsartan single-pill combination by sex in individuals with hypertension

Journal of the American Society of Hypertension, 2015-04, Vol.9 (4), p.e104-e104

2015

Volltextzugriff (PDF)

Plasma renin activity and aldosterone levels in patients with hypertension receiving fixed-dose combination of nebivolol and valsartan: substudy of a phase 3 randomized trial

Journal of the American Society of Hypertension, 2014-04, Vol.8 (4), p.e33-e33

2014

Volltextzugriff (PDF)

Left ventricular hypertrophy decreases slowly but not rapidly activating delayed rectifier potassium currents of epicardial and endocardial myocytes in rabbits

Circulation (New York, N.Y.), 2001-03, Vol.103 (11), p.1585-1590

2001

Volltextzugriff (PDF)

Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure: a randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial (BLAST-AHF)

European heart journal, 2017-08, Vol.38 (30), p.2364-2373

2017

Volltextzugriff (PDF)

MULTI-CENTER, OPEN-LABEL STUDY OF THE EFFICACY AND SAFETY OF ETRIPAMIL NASAL SPRAY SELF-ADMINISTERED FOR MULTIPLE EPISODES OF SYMPTOMATIC SUPRAVENTRICULAR TACHYCARDIA WITHOUT SUPERVISION (PHASE 3, NODE-303)

Journal of the American College of Cardiology, 2024-04, Vol.83 (13), p.3-3

2024

Volltextzugriff (PDF)

SYMPTOM-PROMPTED, SELF-ADMINISTERED INTRANASAL ETRIPAMIL FOR TERMINATION OF PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA IN THE RAPID STUDY: RELATIONSHIP AMONG ETRIPAMIL-INDUCED REDUCTION IN TACHYCARDIA RATES, CONVERSION TO SINUS RHYTHM, AND IMPROVEMENT IN PATIENT SYMPTOMS

Journal of the American College of Cardiology, 2024-04, Vol.83 (13), p.184-184

2024

Volltextzugriff (PDF)

Plain language summary of Publication: Plain language summary of etripamil for atrioventricular-nodal-dependent supraventricular tachycardia

Future cardiology, 2024-02, Vol.20 (2), p.35-44

2024

Volltextzugriff (PDF)

Management and prevention of atrial fibrillation after cardiovascular surgery

The American journal of cardiology, 2000-05, Vol.85 (10), p.20-24

2000

Volltextzugriff (PDF)

Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2023-07, Vol.330 (4), p.328

2023

Volltextzugriff (PDF)

MP-453091-1 EFFECT OF ETRIPAMIL NASAL SPRAY ON VENTRICULAR RATE IN PATIENTS EXPERIENCING SYMPTOMATIC ATRIAL FIBRILLATION

Heart rhythm, 2023-05, Vol.20 (5), p.S109-S109

2023

Volltextzugriff (PDF)

CE-482905-001 SELF-ADMINISTERED ETRIPAMIL NASAL SPRAY RAPIDLY TERMINATED SPONTANEOUS PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA (PSVT): ANALYSIS OF OPEN-LABEL TREATMENT IN THE RAPID STUDY

Heart rhythm, 2024-05, Vol.21 (5), p.S32-S32

2024

Volltextzugriff (PDF)

Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial

The Lancet (British edition), 2023-07, Vol.402 (10396), p.118-128

2023

Volltextzugriff (PDF)

Clinical and Microbiological Outcomes of Ceftazidime-Avibactam Treatment in Adults with Gram-Negative Bacteremia: A Subset Analysis from the Phase 3 Clinical Trial Program

Infectious diseases and therapy, 2021-12, Vol.10 (4), p.2399-2414

2021

Volltextzugriff (PDF)

Relationship between baseline systolic blood pressure and long-term outcomes in acute heart failure patients treated with TRV027: an exploratory subgroup analysis of BLAST-AHF

Clinical research in cardiology, 2018-02, Vol.107 (2), p.170-181

2018

Volltextzugriff (PDF)

Intravenous antiarrhythmic therapy in the acute control of in-hospital destabilizing ventricular tachycardia and fibrillation

The American journal of cardiology, 1999-11, Vol.84 (9), p.46-51

1999

Volltextzugriff (PDF)

Abatacept Pharmacokinetics and Exposure Response in Patients Hospitalized With COVID-19: A Secondary Analysis of the ACTIV-1 IM Randomized Clinical Trial

JAMA network open, 2024-04, Vol.7 (4), p.e247615-e247615

2024

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study

Etripamil Nasal Spray for Recurrent Paroxysmal Supraventricular Tachycardia Conversion

Rationale and design of the NODE-303 study: evaluating the safety of symptom-prompted, self-administered etripamil for paroxysmal supraventricular tachycardia episodes in real-world settings

Plain language summary of the safety and effectiveness of etripamil for atrioventricular-nodal-dependent supraventricular tachycardia: the RAPID study

Design and Rationale of a Phase 2 Study of NeurOtoxin (Botulinum Toxin Type A) for the PreVention of Post-Operative Atrial Fibrillation – The NOVA Study

Results of a curtailed randomized controlled trial, evaluating the efficacy and safety of azimilide in patients with implantable cardioverter defibrillators: The SHIELD-2 trial

Multicenter, Phase 2, Randomized Controlled Study of the Efficacy and Safety of Etripamil Nasal Spray for the Acute Reduction of Rapid Ventricular Rate in Patients With Symptomatic Atrial Fibrillation (ReVeRA-201)

Refinement of the Magnetic Resonance Diffusion-Perfusion Mismatch Concept for Thrombolytic Patient Selection Insights From the Desmoteplase in Acute Stroke Trials

Efficacy of nebivolol‐valsartan single‐pill combination in obese and nonobese patients with hypertension

Efficacy and tolerability of a nebivolol-valsartan single-pill combination by sex in individuals with hypertension

Plasma renin activity and aldosterone levels in patients with hypertension receiving fixed-dose combination of nebivolol and valsartan: substudy of a phase 3 randomized trial

Left ventricular hypertrophy decreases slowly but not rapidly activating delayed rectifier potassium currents of epicardial and endocardial myocytes in rabbits

Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure: a randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial (BLAST-AHF)

MULTI-CENTER, OPEN-LABEL STUDY OF THE EFFICACY AND SAFETY OF ETRIPAMIL NASAL SPRAY SELF-ADMINISTERED FOR MULTIPLE EPISODES OF SYMPTOMATIC SUPRAVENTRICULAR TACHYCARDIA WITHOUT SUPERVISION (PHASE 3, NODE-303)

SYMPTOM-PROMPTED, SELF-ADMINISTERED INTRANASAL ETRIPAMIL FOR TERMINATION OF PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA IN THE RAPID STUDY: RELATIONSHIP AMONG ETRIPAMIL-INDUCED REDUCTION IN TACHYCARDIA RATES, CONVERSION TO SINUS RHYTHM, AND IMPROVEMENT IN PATIENT SYMPTOMS

Plain language summary of Publication: Plain language summary of etripamil for atrioventricular-nodal-dependent supraventricular tachycardia

Management and prevention of atrial fibrillation after cardiovascular surgery

Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial

MP-453091-1 EFFECT OF ETRIPAMIL NASAL SPRAY ON VENTRICULAR RATE IN PATIENTS EXPERIENCING SYMPTOMATIC ATRIAL FIBRILLATION

CE-482905-001 SELF-ADMINISTERED ETRIPAMIL NASAL SPRAY RAPIDLY TERMINATED SPONTANEOUS PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA (PSVT): ANALYSIS OF OPEN-LABEL TREATMENT IN THE RAPID STUDY

Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial

Clinical and Microbiological Outcomes of Ceftazidime-Avibactam Treatment in Adults with Gram-Negative Bacteremia: A Subset Analysis from the Phase 3 Clinical Trial Program

Relationship between baseline systolic blood pressure and long-term outcomes in acute heart failure patients treated with TRV027: an exploratory subgroup analysis of BLAST-AHF

Intravenous antiarrhythmic therapy in the acute control of in-hospital destabilizing ventricular tachycardia and fibrillation

Abatacept Pharmacokinetics and Exposure Response in Patients Hospitalized With COVID-19: A Secondary Analysis of the ACTIV-1 IM Randomized Clinical Trial

Suchergebnisse filtern